Coen Stacy Ann

CIK 00018141502 companiesHOUSTON, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001814150

Recent Transactions

50 trades

Award
FibroBiologics, Inc.$FBLG
Stock Option (Right to Buy)
2025-06-12+22,000→ 22,000 total
Award
FibroBiologics, Inc.$FBLG
Stock Option (Right to Buy)
2024-08-27+5,000→ 5,000 total
Disposition to Issuer
ImmunoGen, Inc.
Restricted Stock Unit
2024-02-12−28,700→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (Right to Buy)
2024-02-12−258,195→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (Right to Buy)
2024-02-12−65,000→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (Right to Buy)
2024-02-12−303,465→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (Right to Buy)
2024-02-12−150,610→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Common Stock
2024-02-12−73,274→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Restricted Stock Unit
2024-02-12−39,293→ 0 total
Sale
ImmunoGen, Inc.
Common Stock
2024-02-05$29.30/sh−4,583→ 73,274 total
Exercise/Conversion
ImmunoGen, Inc.
Common Stock
2024-02-02+14,350→ 77,857 total
Exercise/Conversion
ImmunoGen, Inc.
Restricted Stock Unit
2024-02-02−14,350→ 28,700 total
Award
ImmunoGen, Inc.
Restricted Stock Unit
2024-02-01+39,293→ 39,293 total
Exercise/Conversion
ImmunoGen, Inc.
Stock Option (Right to Buy)
2023-12-29−30,000→ 303,465 total
Award
ImmunoGen, Inc.
Common Stock
2023-12-29$16.01/sh+367→ 63,507 total
Exercise/Conversion
ImmunoGen, Inc.
Common Stock
2023-12-29$5.32/sh+30,000→ 63,140 total
Sale
ImmunoGen, Inc.
Common Stock
2023-11-30$29.20/sh−3,826→ 33,140 total
Exercise/Conversion
ImmunoGen, Inc.
Common Stock
2023-11-17$4.92/sh+2,200→ 39,166 total
Exercise/Conversion
ImmunoGen, Inc.
Stock Option (Right to Buy)
2023-11-17−2,200→ 48,823 total
Exercise/Conversion
ImmunoGen, Inc.
Stock Option (Right to Buy)
2023-11-17−76,023→ 76,787 total
Exercise/Conversion
ImmunoGen, Inc.
Common Stock
2023-11-17$7.69/sh+76,023→ 115,189 total
Sale
ImmunoGen, Inc.
Common Stock
2023-11-17$16.05/sh−78,223→ 36,966 total
Exercise/Conversion
ImmunoGen, Inc.
Stock Option (Right to Buy)
2023-11-16−900→ 152,810 total
Exercise/Conversion
ImmunoGen, Inc.
Common Stock
2023-11-16$4.92/sh+3,200→ 40,166 total
Exercise/Conversion
ImmunoGen, Inc.
Common Stock
2023-11-16$7.69/sh+900→ 41,066 total
Sale
ImmunoGen, Inc.
Common Stock
2023-11-16$16.01/sh−4,100→ 36,966 total
Exercise/Conversion
ImmunoGen, Inc.
Stock Option (Right to Buy)
2023-11-16−3,200→ 51,023 total
Exercise/Conversion
ImmunoGen, Inc.
Stock Option (Right to Buy)
2023-11-15−5,300→ 153,710 total
Exercise/Conversion
ImmunoGen, Inc.
Common Stock
2023-11-15$7.69/sh+5,300→ 63,252 total
Sale
ImmunoGen, Inc.
Common Stock
2023-11-15$16.01/sh−26,286→ 36,966 total
Exercise/Conversion
ImmunoGen, Inc.
Stock Option (Right to Buy)
2023-11-15−20,986→ 54,223 total
Exercise/Conversion
ImmunoGen, Inc.
Common Stock
2023-11-15$4.92/sh+20,986→ 57,952 total
Exercise/Conversion
ImmunoGen, Inc.
Stock Option (Right to Buy)
2023-09-08−26,006→ 159,010 total
Exercise/Conversion
ImmunoGen, Inc.
Common Stock
2023-09-08$7.69/sh+26,006→ 36,966 total
Exercise/Conversion
ImmunoGen, Inc.
Common Stock
2023-08-09$4.92/sh+100,210→ 111,170 total
Exercise/Conversion
ImmunoGen, Inc.
Stock Option (Right to Buy)
2023-08-09−100,210→ 75,209 total
Sale
ImmunoGen, Inc.
Common Stock
2023-08-09$14.20/sh−100,210→ 10,960 total
Sale
ImmunoGen, Inc.
Common Stock
2023-08-04$17.05/sh−80,326→ 10,960 total
Exercise/Conversion
ImmunoGen, Inc.
Stock Option (Right to Buy)
2023-08-04−80,326→ 175,419 total
Exercise/Conversion
ImmunoGen, Inc.
Common Stock
2023-08-04$4.92/sh+80,326→ 91,286 total
Exercise/Conversion
ImmunoGen, Inc.
Stock Option (Right to Buy)
2023-08-02−4,255→ 255,745 total
Exercise/Conversion
ImmunoGen, Inc.
Common Stock
2023-08-02$4.92/sh+4,255→ 15,215 total
Sale
ImmunoGen, Inc.
Common Stock
2023-08-02$18.12/sh−4,255→ 10,960 total
Award
ImmunoGen, Inc.
Common Stock
2023-06-30$4.05/sh+3,792→ 10,960 total
Award
ImmunoGen, Inc.
Stock Option (right to buy)
2023-02-03+245,900→ 245,900 total
Award
ImmunoGen, Inc.
Restricted Stock Unit
2023-02-03+41,000→ 41,000 total
Award
ImmunoGen, Inc.
Stock Option (Right to Buy)
2022-11-14+60,000→ 90,000 total
Award
ImmunoGen, Inc.
Common Stock
2022-06-30$3.83/sh+3,342→ 7,168 total
Award
ImmunoGen, Inc.
Stock Option (Right to Buy)
2022-05-20+30,000→ 30,000 total
Award
ImmunoGen, Inc.
Common Stock (right to buy)
2022-02-04$5.32/sh+333,465→ 333,465 total

Companies

Recent Filings

Address

C/O FIBROBIOLOGICS, INC. 455 E. MEDICAL CENTER BLVD. SUITE 300

HOUSTON, TX, 77598

View on SEC.gov